English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Psychoses associated with use of modern synthetic psychoactive substances (PAS) have significant differences in clinical features for making accurate diagnosis. These features play important role in correct diagnosis of psychoses, associated with synthetic cannabis (spice), synthetic stimulants (bath salts), and synthetic GABA-agonists (butyrates) still badly investigated.&#x0D;Theaimof this study was to reveal main symptoms and syndromes of psychoses associated with modern synthetic PAS.&#x0D;Methods: clinical and psychopathological, laboratory, statistical.&#x0D;Results. We examined 154patients with psychoses associated with modern synthetic PAS: 53users of synthetic cannabinoids (spices), 54users of synthetic psychostimulants (cathinones, metcathinones, bath salts), and 47users of synthetic GABA-agonists (butyrolactone).&#x0D;Conclusion. Differences in psychotic symptoms in different groups are described.

Clinical structure of psychoses, associated with use of modern synthetic psychoactive substances